LeeDHWatsonKEAl HamarnehYN.Impact of COVID-19 on frontline pharmacists’ roles and services in Canada: the INSPIRE survey. Can Pharm J (Ott)2021;154:368-73.
2.
TsuyukiRTHouleSKCharroisTL, et al. Randomized trial of the effect of pharmacist prescribing on improving blood pressure in the community: the Alberta clinical trial in optimizing hypertension (RxACTION). Circulation2015;132:93-100.
3.
SantschiVChioleroAColosimoAL, et al. Improving blood pressure control through pharmacist interventions: a meta-analysis of randomized controlled trials. J Am Heart Assoc2014;3:e000718.
4.
TsuyukiRTAroraVBarnesM, et al. Canadian national consensus guidelines for naloxone prescribing by pharmacists. Can Pharm J (Ott)2020;153:347-51.
5.
TsuyukiRTDaviesNM.Self-denigration in pharmacy: words to banish from the pharmacy lexicon. Can Pharm J (Ott)2014;147:197-9.
6.
DaviesNMTsuyukiRT.Self-denigration in pharmacy: actions that should be curtailed. Can Pharm J (Ott)2014;147:265-6.
7.
GyselSCWatsonKETsuyukiRT.Appropriate staffing for pharmacists’ full scope of practice. Can Pharm J (Ott)2022;155:136-8. doi:10.1177/17151635221091191
8.
ChanJCTsuyukiRT.Pharmacists can improve hypertension care (but you have to pay them . . .): a review of remuneration opportunities across Canada. Can Pharm J (Ott)2020;153:7-8. doi:10.1177/1715163519892207
9.
TsuyukiRTAl HamarnehYNChanJCH, et al. Pharmacy, we have an image problem . . . (and here’s a solution). Can Pharm J (Ott)2021;154:353-4. doi:10.1177/17151635211050029
10.
GyselSTsuyukiRT.Overcoming stigma in pharmacy practice. Can Pharm J (Ott)2022;155:4-5.
